MENU
MYGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Myriad Genetics (MYGN) Earnings Date & Reports
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
MYGN is expected to report earnings to fall 33.33% to -5 cents per share on July 30
Q2'26
Est.
$-0.06
Q1'26
Missed
by $0.02
Q4'25
Beat
by $0.06
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.06
The last earnings report on May 05 showed earnings per share of -9 cents, missing the estimate of -7 cents. With 1.19M shares outstanding, the current market capitalization sits at 408.96M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of therapeutic and predictive medicine products
Industry MedicalSpecialties
Profile
Details
Industry
Biotechnology
Address
322 North 2200 West
Phone
+1 801 584-3600
Employees
2700
Web
https://www.myriad.com